Multidimensional Screening and Intervention Program for Neurocognitive Disorder in Vascular and Multimorbid Outpatients: Study Protocol for a Randomized Clinical Trial
Abstract
The study aims to develop innovative strategies for individuals with dementia secondary to cerebrovascular or other medical diseases. It emphasizes the importance of physical and cognitive activities in protecting against cognitive decline.
Methods
The study’s primary objectives include identifying patients affected by neurocognitive disorder due to vascular disease or multiple etiologies and evaluating the effectiveness of distinct rehabilitation protocols: motor training alone, paper-based cognitive rehabilitation combined with motor training, and digital-based cognitive rehabilitation coupled with motor training.
Discussion
Identifying cognitive impairment beyond rigid neurological contexts can facilitate timely and targeted interventions. The protocol addresses the complex interplay of cognitive decline and comorbidities through a multidimensional approach, providing insights for future interventions and enhancing overall well-being in this vulnerable population.
Trial Registration
The study has been registered with the ClinicalTrials.gov NCT05954741 registration number.
ClinicalTrials.gov NCT05954741
PMID:38985746 | DOI:10.1371/journal.pone.0306256
Clinical Trials and AI-Driven Solutions
Clinical trials play a crucial role in developing safe and effective treatments. At DocSym, our AI-driven platform consolidates ICD-11 standards, clinical protocols, and research into an easily accessible knowledge base for clinicians, extending the benefits of clinical trials into everyday medical practice.
Streamlining operations is crucial in today’s healthcare environment. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.
By using AI, clinics can enhance their workflows, improve patient outcomes, and reduce paper routines. Learn more about how we can help at aidevmd.com.